Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia
Emma-Jayne Minihane(Dana-Farber Cancer Institute), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Amulya Jakkani(Dana-Farber Cancer Institute), Eric S. Winer(Providence College), Anthony Letai(Dana-Farber Cancer Institute), Marlise R. Luskin(Dana-Farber Cancer Institute), Rahul S. Vedula(Harvard University), Martha Wadleigh(Dana-Farber Cancer Institute), Shai Shimony(Twitter (United States)), Evan C. Chen(Dana-Farber Cancer Institute), Ilene Galinsky(Dana-Farber Cancer Institute), Sonja Herter(German Cancer Research Center), Jeremy Ryan(Dana-Farber Cancer Institute), Geoffrey Fell(Harvard University), Christopher R. Reilly(Dana-Farber Cancer Institute), Virginia O. Volpe(UConn Health), Andrew A. Lane(Dana-Farber Cancer Institute), Richard M. Stone(Dana-Farber Cancer Institute), Lindsey Thornton(Dana-Farber Cancer Institute), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Jason Wu(The George Institute for Global Health), Leah Krotee(Dana-Farber Cancer Institute), Kate Marinchev(Dana-Farber Cancer Institute), Donna Neuberg(Otsuka (Japan))
Cited by 1
Related Papers
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k